نتایج جستجو برای: biolimus
تعداد نتایج: 252 فیلتر نتایج به سال:
The majority of percutaneous coronary intervention cases are performed using drug eluting stents. Trials have consistently demonstrated lower rates of in stent restenosis and repeat revascularization with drug eluting stents when compared with bare metal stents. Stent technology has improved over the decade with changes in the thickness of stent struts, polymer coating and ease of stent deliver...
Fro ini Du an res da Bio (CR Lis Yo Ma BACKGROUND The first CE-approved bioresorbable vascular scaffold (BVS) is effective at treating simple lesions and stable coronary artery disease, but it has yet to be assessed versus the best-in-class drug-eluting stents (DES). OBJECTIVES This study sought to compare the performance of a BVS with that of everolimus-eluting stents (EES) and biolimus-elutin...
the invention of the drug-eluting stent (des) has brought about revolutionary changes in the field of interventional cardiology. in the des era, in-stent restenosis has declined but new issues such as stent thrombosis have emerged. one of the emerging paradigms in the des era is stent fracture. there are reports about stent fracture leading to in-stent restenosis or stent thrombosis. most of th...
AIMS The current study reports clinical outcomes at three year follow-up of the LEADERS clinical trial which was the first all-comers trial comparing a new generation biodegradable polymer biolimus drug-eluting stent (BES) with the first generation permanent polymer sirolimus-eluting stent (SES). METHODS AND RESULTS One thousand seven hundred and seven patients were randomised to unrestricted...
Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید